[Tissue Penetration of Antibiotics. Does the Treatment Reach the Target Site?]

Overview

Journal Med Klin Intensivmed Notfmed

Specialties Critical Care
General Medicine

Date 2014 Apr 3

PMID 24691884

Citations 3

Authors

H Lagler

M Zeitlinger

Affiliations

Soon will be listed here.

Abstract

Background: For critically ill patients, infections still imply a major challenge for the treating physician. One key factor of successful treatment is sufficient exposure of the employed antimicrobial agent at the site of infection. In most cases, this is the interstitial space of the infected organ or a body cavity; much rarer vital bacteria are located within body cells.

Methods: Different methods for assessment of tissue pharmacokinetics of antimicrobial agents in the human body are described, including tissue biopsy, bronchoalveolar lavage and microdialysis, and their implication on interpretation of obtained data are discussed. Tissue pharmacokinetics of the hydrophilic beta-lactam meropenem and the lipophilic fluoroquinolone levofloxacin are compared.

Results: Differences in pharmacokinetics between plasma and tissue, healthy volunteers and critically ill patients but also between data obtained in the same organ by different methods are discussed.

Conclusion: In order to use pharmacokinetic data to optimize the treatment of critically ill patients, critical appraisal of the causative pathogen, the location of the infection, and the source of the used pharmacokinetic data is necessary.

Citing Articles

Amphotericin B tissue penetration and pharmacokinetics in healthy and -infected rats: insights from microdialysis and population modeling.

Santos V, Pereira L, de Araujo J, Borges M, Brandao C, Santos L Front Pharmacol. 2025; 15:1515462.

PMID: 39867661 PMC: 11757102. DOI: 10.3389/fphar.2024.1515462.

24/7 Therapeutic Drug Monitoring of Beta-Lactam Antibiotics with CLAM-2000.

Khromov T, Dihazi G, Brockmeyer P, Fischer A, Streit F Antibiotics (Basel). 2023; 12(10).

PMID: 37887227 PMC: 10604791. DOI: 10.3390/antibiotics12101526.

Nanoparticle-based local antimicrobial drug delivery.

Gao W, Chen Y, Zhang Y, Zhang Q, Zhang L Adv Drug Deliv Rev. 2017; 127:46-57.

PMID: 28939377 PMC: 5860926. DOI: 10.1016/j.addr.2017.09.015.

[Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?].

Brinkmann A, Rohr A, Koberer A, Fuchs T, Preisenberger J, Kruger W Med Klin Intensivmed Notfmed. 2016; 113(2):82-93.

PMID: 27624768 DOI: 10.1007/s00063-016-0213-5.

References

Karjagin J, Lefeuvre S, Oselin K, Kipper K, Marchand S, Tikkerberi A . Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock. Clin Pharmacol Ther. 2007; 83(3):452-9. DOI: 10.1038/sj.clpt.6100312. View

Zhanel G, Dueck M, Hoban D, Vercaigne L, Embil J, Gin A . Review of macrolides and ketolides: focus on respiratory tract infections. Drugs. 2001; 61(4):443-98. DOI: 10.2165/00003495-200161040-00003. View

Hukagawa H, Noga K . [A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients]. Jpn J Antibiot. 1992; 45(3):253-7. View

Marcy T, Merrill W, Rankin J, Reynolds H . Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. Am Rev Respir Dis. 1987; 135(6):1276-80. DOI: 10.1164/arrd.1987.135.6.1276. View

Ryan D . Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother. 1993; 31 Suppl D:1-16. DOI: 10.1093/jac/31.suppl_d.1. View

Gotfried M, Danziger L, Rodvold K . Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest. 2001; 119(4):1114-22. DOI: 10.1378/chest.119.4.1114. View

Zeitlinger B, Zeitlinger M, Leitner I, Muller M, Joukhadar C . Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis. Clin Pharmacokinet. 2007; 46(1):75-83. DOI: 10.2165/00003088-200746010-00004. View

Rennard S, BASSET G, Lecossier D, ODonnell K, Pinkston P, Martin P . Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985). 1986; 60(2):532-8. DOI: 10.1152/jappl.1986.60.2.532. View

Byl B, Jacobs F, Roucloux I, de Franquen P, Cappello M, Thys J . Penetration of meropenem in lung, bronchial mucosa, and pleural tissues. Antimicrob Agents Chemother. 1999; 43(3):681-2. PMC: 89181. DOI: 10.1128/AAC.43.3.681. View

10.

Robatel C, Decosterd L, Biollaz J, Eckert P, Schaller M, Buclin T . Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients. J Clin Pharmacol. 2003; 43(12):1329-40. DOI: 10.1177/0091270003260286. View

11.

Fujita A, Miya T, Tanaka R, Hirayama S, Isaka H, Ono Y . [Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint]. Jpn J Antibiot. 2000; 52(11):661-6. View

12.

Elmquist W, Sawchuk R . Application of microdialysis in pharmacokinetic studies. Pharm Res. 1997; 14(3):267-88. DOI: 10.1023/a:1012081501464. View

13.

Nishikawa G, Ikawa K, Nakamura K, Yamada Y, Zennami K, Mitsui K . Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation. Int J Antimicrob Agents. 2013; 41(3):267-71. DOI: 10.1016/j.ijantimicag.2012.11.001. View

14.

Pea F, Pavan F, Nascimben E, Benetton C, Scotton P, Vaglia A . Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrob Agents Chemother. 2003; 47(10):3104-8. PMC: 201115. DOI: 10.1128/AAC.47.10.3104-3108.2003. View

15.

Bergogne-Berezin E, Muller-Serieys C, Aubier M, Dombret M . Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy. Eur J Clin Pharmacol. 1994; 46(1):87-8. DOI: 10.1007/BF00195922. View

16.

Davis R, Bryson H . Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs. 1994; 47(4):677-700. DOI: 10.2165/00003495-199447040-00008. View

17.

Andrews J, Honeybourne D, Jevons G, Brenwald N, Cunningham B, Wise R . Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother. 1997; 40(4):573-7. DOI: 10.1093/jac/40.4.573. View

18.

Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig W . Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 1988; 158(4):831-47. DOI: 10.1093/infdis/158.4.831. View

19.

Goncalves-Pereira J, Povoa P . Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams. Crit Care. 2011; 15(5):R206. PMC: 3334750. DOI: 10.1186/cc10441. View

20.

Dagan R, VELGHE L, Rodda J, Klugman K . Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrob Chemother. 1994; 34(1):175-9. DOI: 10.1093/jac/34.1.175. View